BridgeBio Pharma Inc. (NASDAQ: BBIO) reported Q3 EPS of ($1.06), $0.16 worse than the analyst estimate of ($0.90).

For earnings history and earnings-related data on BridgeBio Pharma Inc. (BBIO) click here.